Clinical timing, risk, and approval estimates for upcoming GLP-1 U.S
Broadly, studies suggest GLP-1RAs exert their neuroprotective effects in the retina by mediating reduced glutamate excitotoxicity, decreased neuroinflammation, prevention of retinal ganglion cell (RGC) loss, promotion of vascular integrity, promotion of an anti-oxidative environment, and maintenance of glial cells (i.e
RK Rachel K
Studies were screened based on title and abstract for relevance
Dr Jake Violi of UNSW said there was definitely no GLP-1 or any other identifiable drug molecules in the sample, which was very salty and appeared to be simply eye drops or some similar product
Blood plasma analysis via LC-MS/MS (liquid chromatography-tandem mass spectrometry) can detect Melanotan-1 within the 810 hour clearance window, but this requires targeted analysis with known reference standards